Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Citius Pharmaceuticals, Inc. (CTXR) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Citius Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1506251.
Total stock buying since 2016: $15,805,707.
Total stock sales since 2016: $0.
Total stock option exercises since 2016: $217.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 0 | $0 | 14,486 | $217 |
| 2019 | 4,087,795 | $4,499,999 | 0 | $0 | 0 | $0 |
| 2018 | 4,091,988 | $5,509,006 | 0 | $0 | 0 | $0 |
| 2017 | 656,506 | $2,796,702 | 0 | $0 | 0 | $0 |
| 2016 | 5,000,000 | $3,000,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-03 | 0 | $0 | 0 | $0 | 14,486 | $217 |
| 2019-09 | 2,793,297 | $2,500,000 | 0 | $0 | 0 | $0 |
| 2019-04 | 1,294,498 | $1,999,999 | 0 | $0 | 0 | $0 |
| 2018-08 | 3,921,569 | $5,000,000 | 0 | $0 | 0 | $0 |
| 2018-03 | 170,419 | $509,006 | 0 | $0 | 0 | $0 |
| 2017-12 | 213,106 | $999,467 | 0 | $0 | 0 | $0 |
| 2017-08 | 443,400 | $1,797,235 | 0 | $0 | 0 | $0 |
| 2016-03 | 5,000,000 | $3,000,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-03-13 | Holuka Eugene Myron | Option Ex | 2,415 | .01 | 36 |
| 2024-03-04 | Webb Carol | Option Ex | 12,071 | .01 | 181 |
| 2019-09-27 | Mazur Leonard L (Executive Chairman) | Buy | 2,234,700 | .90 | 2,000,056 |
| 2019-09-27 | Holubiak Myron Z (President and CEO) | Buy | 558,597 | .90 | 499,944 |
| 2019-04-03 | Mazur Leonard L (Executive Chairman) | Buy | 1,165,048 | 1.54 | 1,799,999 |
| 2019-04-03 | Holubiak Myron Z (President and CEO) | Buy | 129,450 | 1.54 | 200,000 |
| 2018-08-13 | Mazur Leonard L (Executive Chairman) | Buy | 3,137,255 | 1.27 | 4,000,000 |
| 2018-08-13 | Holubiak Myron Z (President and CEO) | Buy | 784,314 | 1.27 | 1,000,000 |
| 2018-03-29 | Mazur Leonard L (Executive Chairman) | Buy | 167,504 | 2.98 | 499,999 |
| 2018-03-28 | Holubiak Myron Z (President and CEO) | Buy | 2,915 | 3.09 | 9,007 |
| 2017-12-19 | Mazur Leonard L (Executive Chairman) | Buy | 213,106 | 4.69 | 999,467 |
| 2017-08-01 | Mazur Leonard L (Executive Chairman) | Buy | 432,400 | 3.40 | 1,767,755 |
| 2016-03-01 | Mazur Leonard L | Buy | 5,000,000 | .60 | 3,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of CTXR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Citius Pharmaceuticals, Inc. (symbol CTXR, CIK number 1506251) see the Securities and Exchange Commission (SEC) website.